BiotechTube
Home/DeepCure/Han Lim
HL

Han Lim

Chief Business Officer

DeepCure

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesImmunology

DeepCure Pipeline

DrugIndicationPhase
DC-9476 (BRD4-BD2 inhibitor)Rheumatoid Arthritis, Still's Disease, Hidradenitis SuppurativaIND-Enabling
DC-15442 (STAT6 inhibitor)Asthma, Atopic DermatitisIND-Enabling
TNFα programAuto-immune indicationsEarly Discovery

Leadership Team at DeepCure

KS
Kfir Schreiber
CEO & Co-Founder
T(
Thrasyvoulos (Thras) Karydis
CTO & Co-Founder
LR
Luca Rastelli
Chief Scientific Officer
JJ
Joseph Jacobson
Co-Founder
View full DeepCure profile